Form 4 for ICU SeaStar Medical Holding Corp
Accepted 2023-11-29 00:00:00 ET · period of report 2023-09-22 · accession 0000929638-23-003300 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-29 | 2023-09-22 | ICU | Baron Caryl | Interim CFO | J - Other | $0.00 | +15.1K | 119.6K | +14% | $0 | |
| 2023-11-29 | 2023-11-29 | ICU | Baron Caryl | Interim CFO | A - Grant | $0.00 | +20.3K | 139.9K | +17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2023-09-22 | J | A | 15,070 | $0.00 | 119,579 | D | — | — | (F1) Represents fully vested shares of common stock issued to the Reporting Person pursuant to the Issuer's equity incentive plan. The securities reported in this transaction were initially withheld by the Issuer to satisfy tax withholding obligations. The Issuer subsequently elected to satisfy the withholding obligations through an alternative method and returned these shares to the Reporting Person. (F2) Due to rounding errors, (i) the Form 4 filed for the Reporting Person on August 17, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 15, 2023 by 1 share, (ii) the Form 4 filed for the Reporting Person on September 12, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 31, 2023 by 1 share, and (iii) the Form 4 filed for the Reporting Person on September 19, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on September 15, 2023 by 1 share. These errors have been corrected on this Form 4. |
| 2 | Common | Common Stock, par value $0.0001 per share | 2023-11-29 | A | A | 20,293 | $0.00 | 139,872 | D | — | — | (F3) The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee. (F2) Due to rounding errors, (i) the Form 4 filed for the Reporting Person on August 17, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 15, 2023 by 1 share, (ii) the Form 4 filed for the Reporting Person on September 12, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 31, 2023 by 1 share, and (iii) the Form 4 filed for the Reporting Person on September 19, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on September 15, 2023 by 1 share. These errors have been corrected on this Form 4. |